Cargando…

Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients

SIMPLE SUMMARY: In cervical neoplasia, tissue methylation of CADM1 and MAL has been identified as a promising triage tool for HPV-positive women. Here, we performed an exploratory study on the potential of the methylated genes as combined markers for the analysis of cervical smears and peripheral bl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leffers, Markus, Herbst, Johanna, Kropidlowski, Jolanthe, Prieske, Katharina, Bohnen, Anna Lena, Peine, Sven, Jaeger, Anna, Oliveira-Ferrer, Leticia, Goy, Yvonne, Schmalfeldt, Barbara, Pantel, Klaus, Wölber, Linn, Effenberger, Katharina, Wikman, Harriet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406083/ https://www.ncbi.nlm.nih.gov/pubmed/36010947 http://dx.doi.org/10.3390/cancers14163954

Ejemplares similares

Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions
por: Herbst, Johanna, et al.
Publicado: (2022)

Loss of CADM1 expression is associated with poor prognosis and brain metastasis in breast cancer patients
por: Wikman, Harriet, et al.
Publicado: (2014)

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

Impact of Introducing a PACU24 Concept on the Perioperative Outcome of Patients with Advanced Ovarian Cancer Treated with Cytoreductive Surgery
por: Reuter, Susanne, et al.
Publicado: (2023)

Clinical Relevance of Loss of 11p15 in Primary and Metastatic Breast Cancer: Association with Loss of PRKCDBP Expression in Brain Metastases
por: Wikman, Harriet, et al.
Publicado: (2012)

VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients
por: Ding, Yi, et al.
Publicado: (2022)

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay
por: Belloum, Yassine, et al.
Publicado: (2020)

Loss of BRCA1 promotor hypermethylation in recurrent high-grade ovarian cancer
por: Prieske, Katharina, et al.
Publicado: (2017)

Targeted Therapeutic Approaches in Vulvar Squamous Cell Cancer (VSCC): Case Series and Review of the Literature
por: Woelber, Linn, et al.
Publicado: (2021)

VEGF-C expression attributes the risk for lymphatic metastases to ovarian cancer patients
por: Kuerti, Sascha, et al.
Publicado: (2017)

Transcriptome Analysis in Vulvar Squamous Cell Cancer
por: Prieske, Katharina, et al.
Publicado: (2021)

Circulating Cancer Associated Macrophage-like Cells as a Potential New Prognostic Marker in Pancreatic Ductal Adenocarcinoma
por: Nitschke, Christine, et al.
Publicado: (2022)

CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions
por: del Pino, Marta, et al.
Publicado: (2019)

Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia
por: Phillips, Samuel, et al.
Publicado: (2022)

Characterization of RARRES1 Expression on Circulating Tumor Cells as Unfavorable Prognostic Marker in Resected Pancreatic Ductal Adenocarcinoma Patients
por: Nitschke, Christine, et al.
Publicado: (2022)

Breast cancer brain metastases: biology and new clinical perspectives
por: Witzel, Isabell, et al.
Publicado: (2016)

Clonality of circulating tumor cells in breast cancer brain metastasis patients
por: Riebensahm, Carlotta, et al.
Publicado: (2019)

Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients
por: Koch, Claudia, et al.
Publicado: (2020)

Human Papillomavirus Genotypes and Methylation of CADM1, PAX1, MAL and ADCYAP1 Genes in Epithelial Ovarian Cancer Patients
por: Hassan, Zeinab K, et al.
Publicado: (2017)

Methylation of CADM1 and MAL together with HPV status in cytological cervical specimens serves an important role in the progression of cervical intraepithelial neoplasia
por: Meršaková, Sandra, et al.
Publicado: (2018)

Comparative evaluation of PD‐L1 expression in cytology imprints, circulating tumour cells and tumour tissue in non‐small cell lung cancer patients
por: Abdo, Mustafa, et al.
Publicado: (2023)

Loss of 4q21.23-22.1 Is a Prognostic Marker for Disease Free and Overall Survival in Non-Small Cell Lung Cancer
por: Uzunoglu, Faik G., et al.
Publicado: (2014)

Comparison of PapilloCheck and Linear Array to Detect and Differentiate Human Papillomaviruses in Cervical and Tonsillar Smears from Females with Cervical Intraepithelial Lesions
por: Grimm, Donata, et al.
Publicado: (2018)

Expression profile of CADM1 and CADM4 in triple negative breast cancer with primary systemic therapy
por: Kanke, Yasuyuki, et al.
Publicado: (2019)

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2023)

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
por: Scharpenseel, Heather, et al.
Publicado: (2019)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
por: Keller, Laura, et al.
Publicado: (2020)

Pelvic lymphadenectomy in vulvar cancer and its impact on prognosis and outcome
por: Jaeger, A., et al.
Publicado: (2021)

E-Cadherin fragments as potential mediators for peritoneal metastasis in advanced epithelial ovarian cancer
por: Trillsch, Fabian, et al.
Publicado: (2016)

The Treatment of Mal-Positions and Mal-Presentations
por: Jardine, Robert
Publicado: (1918)

CADM1 associates with Hippo pathway core kinases; membranous co–expression of CADM1 and LATS2 in lung tumors predicts good prognosis
por: Ito, Takeshi, et al.
Publicado: (2019)

Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data
por: He, Hui, et al.
Publicado: (2022)

Cadm2 regulates body weight and energy homeostasis in mice
por: Yan, Xin, et al.
Publicado: (2017)

Replication and characterization of CADM2 and MSRA genes on human behavior
por: Boutwell, Brian, et al.
Publicado: (2017)

Epilepsy, Grand Mal, Petit Mal Convulsions
por: Glaser, Gilbert H.
Publicado: (1957)

Spontaneous development of lung adenocarcinoma in the CADM1 gene-deficient mice
por: Nagata, Masayoshi, et al.
Publicado: (2010)

The performance of the Congruence Among Distance Matrices (CADM) test in phylogenetic analysis
por: Campbell, Véronique, et al.
Publicado: (2011)

Increased tumorigenesis associated with loss of the tumor suppressor gene Cadm1
por: van der Weyden, Louise, et al.
Publicado: (2012)

CADM1 is a TWIST1-regulated suppressor of invasion and survival
por: Hartsough, Edward J., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qnud6i2v8b9tr0gbqk4rf1jh2o